Publications by authors named "Jonathan Laye"

Claim this Profile
M
Mutually exclusive genetic interactions and gene essentiality shape the genomic landscape of primary melanoma.
Sofia Birkeälv, Mark Harland, Larissa Satiko Alcantara Sekimoto Matsuyama, Mamun Rashid, Ishan Mehta, Jonathan P Laye

J Pathol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma.
Rohit Thakur, Jonathan P Laye, Martin Lauss, Joey Mark S Diaz, Sally Jane O'Shea

Clin Cancer Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D-VDR Signaling Inhibits Wnt/β-Catenin-Mediated Melanoma Progression and Promotes Antitumor Immunity.
Sathya Muralidhar, Anastasia Filia, Jérémie Nsengimana, Joanna Poźniak, Sally J O'Shea, Jonathan P Laye

Cancer Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic and Environmental Determinants of Immune Response to Cutaneous Melanoma.
Joanna Poźniak, Jérémie Nsengimana, Jonathan P Laye, Sally J O'Shea, Joey Mark S Diaz

Cancer Res· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Significance of Promoter Hypermethylation and Diminished Gene Expression of SYNPO2 in Melanoma.
Linda Gao, Karin van den Hurk, Jérémie Nsengimana, Jonathan P Laye, Joost J van den Oord

J Invest Dermatol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinicopathological and gene expression patterns associated with ulceration of primary melanoma.
Rosalyn Jewell, Faye Elliott, Jonathan Laye, Jérémie Nsengimana, John Davies

Pigment Cell Melanoma Res· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity of a duocarmycin analogue rationalized to be metabolically activated by cytochrome P450 1A1 in human transitional cell carcinoma of the bladder.
Mark Sutherland, Jason H Gill, Paul M Loadman, Jonathan P Laye, Helen M Sheldrake

Mol Cancer Ther· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-resolution deletion mapping of 15q13.2-q21.1 in transitional cell carcinoma of the bladder.
Rachael Natrajan, Jari Louhelainen, Sarah Williams, Jonathan Laye, Margaret A Knowles

Cancer Res· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phospholipase A2 expression in tumours: a target for therapeutic intervention?
Jonathan P Laye, Jason H Gill

Drug Discov Today· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis